About Mviyes Pharma Ventures Private Limited
Data last updated:
Mviyes Pharma Ventures Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Aurobindo Pharma Ltd. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 March 2017.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2017PTC116265. Its GSTIN is 36AAKCM9609A1ZG (Telangana).
The company had an authorised share capital of ₹150.25 Cr and a paid-up capital of ₹150.25 Cr. It was led by directors including Madadi Venkat Reddy (Whole-Time Director) and Sapna.
Its last annual general meeting (AGM) was held on 19 June 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Galaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
As per the financials filed for FY 2023, the company reported a revenue of ₹20.38 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹15.92 Lakh (net margin 78.1%) and EBITDA of ₹15.92 Lakh (EBITDA margin 78.1%).
The company was associated with 1 brand: Aurobindo Pharma. As per MCA filings, the company had satisfied charges of ₹675 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company. The company has 11 deals on record (9 secondary share transfers, 2 funding rounds), with disclosed funding of ₹87.54 Cr; the latest was in October 2020.
The last known website on record is aurobindo.com.
Company details
Contact details
Mviyes Pharma Ventures Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Social Media
- Registered AddressGalaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mviyes Pharma Ventures Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Mviyes Pharma Ventures operates one associated brand: Aurobindo Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Generic biocatalytic solutions are provided for pharmaceutical applications. | aurobindo.com |
Business activity
The main business activity of Mviyes Pharma Ventures is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mviyes Pharma Ventures Private Limited, buy the company report.
Financials of Mviyes Pharma Ventures Private Limited
FY 2023 filings availableMviyes Pharma Ventures Private Limited reported revenue of ₹20.38 Lakh (up 477% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 477% in the latest year. EBITDA rose 701% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹20.38 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 78.1% | ||||
| Net Profit Margin | 78.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mviyes Pharma Ventures Private Limited, buy the company report.
Board of directors and KMP of Mviyes Pharma Ventures Private Limited
Mviyes Pharma Ventures Private Limited currently reports 3 directors and 1 key managerial person. 14 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Thomas Koshy Vellutheril | Cfo | 01 Jul 2021 | 5 Years 4 Months | As last reported |
| Sapna Also directs: Aurigene Pharmaceutical Services Limited | Director | 23 Oct 2020 | 6 Years 0 Months | As last reported |
| Madadi Venkat Reddy | Whole-Time Director | 01 Jul 2021 | 5 Years 4 Months | As last reported |
| Suryanarayana Murthy Mula Also directs: Apl Healthcare Limited, Aurozest Private Limited | Director | 23 Oct 2020 | 6 Years 0 Months | As last reported |
Auditor
Mviyes Pharma Ventures Private Limited is audited by G P M & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G P M & ASSOCIATES | FY 2023 | 015343S |
Shareholding
The shareholding of Mviyes Pharma Ventures Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mviyes Pharma Ventures Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Sep 2019 | 100295902 | Others | ₹675 Cr | Satisfied |
To see the full charge records of Mviyes Pharma Ventures Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Mviyes Pharma Ventures Private Limited has 11 deals on record (9 secondary share transfers, 2 funding rounds), with disclosed funding of ₹87.54 Cr; the latest was in October 2020.
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2020 | Secondary share transfer | Undisclosed | Buyer: Aurobindo Pharma Ltd , Aurobindo Pharma Limited & K Nitya Nanda Reddy Seller: Radhanga Real Estate Developers Private Limited , Iquest Enterprises Private Limited , Jupally Real Estate Developers Private Limited , an individual |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Jan 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Nov 2019 | Funding round | ₹42.95 Cr | Investors: Jupally Real Estate Developers Private Limited , Iquest Enterprises Private Limited , 2 individuals |
| Apr 2019 | Funding round | ₹44.6 Cr | Investors: Radhanga Real Estate Developers Private Limited , Sharp Ventures, Peak XV Partners (Sequoia India and SEA), an individual |
To see the full deal history of Mviyes Pharma Ventures Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Mviyes Pharma Ventures Private Limited has 4 court cases on record: 4 filed by Mviyes Pharma Ventures. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 4 | 0 | 0 |
Cases on record (3 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Interim or miscellaneous application | Filed by the company | Disposed |
| NCLT, Hyderabad | Court case (C.A.(CAA)) | Filed by the company | Disposed |
| NCLT, Hyderabad | Court case (C.P.(CAA)) | Filed by the company | Disposed |
To see the full case history of Mviyes Pharma Ventures Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mviyes Pharma Ventures Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mviyes Pharma Ventures has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAKCM9609A1ZG | Telangana | Active | 01 Nov 2018 |
To see the full GST registrations and return filing status of Mviyes Pharma Ventures Private Limited, buy the company report.
Recent activity
Mviyes Pharma Ventures Private Limited has 17 board changes on record since 2018: 4 appointments and 13 cessations. The latest: Sapna ceased to be Additional Director on 24 Aug 2021.
11 earlier events are in the company report.
News
Frequently asked questions
Mviyes Pharma Ventures has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Mviyes Pharma Ventures was a private limited company based in Hyderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 30 March 2017 and is registered under CIN U74999TG2017PTC116265. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Mviyes Pharma Ventures was incorporated on 30 March 2017. It is registered with the Registrar of Companies, Hyderabad.
Mviyes Pharma Ventures had 4 directors and KMP:
- Madadi Venkat Reddy - Whole-Time Director
- Sapna - Director
- Suryanarayana Murthy Mula - Director
- Thomas Koshy Vellutheril - Cfo
The CIN (Corporate Identification Number) of Mviyes Pharma Ventures is U74999TG2017PTC116265. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Mviyes Pharma Ventures is at Galaxy Floors 22 – 24 Plot No. 1 Survey No. 831 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
Mviyes Pharma Ventures can be reached through the website aurobindo.com. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of Mviyes Pharma Ventures on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 19 June 2023. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Mviyes Pharma Ventures is 36AAKCM9609A1ZG, registered in Telangana.
Mviyes Pharma Ventures operated in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
